TD Asset Management Inc. lessened its holdings in Nutrien Ltd (NYSE:NTR) by 5.5% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 7,815,258 shares of the company’s stock after selling 451,519 shares during the period. Nutrien accounts for about 0.6% of TD Asset Management Inc.’s portfolio, making the stock its 28th biggest position. TD Asset Management Inc.’s holdings in Nutrien were worth $418,914,000 as of its most recent SEC filing.
Other large investors have also modified their holdings of the company. Icon Wealth Partners LLC purchased a new position in shares of Nutrien during the 1st quarter valued at approximately $35,000. Bessemer Group Inc. lifted its position in shares of Nutrien by 354.4% during the 2nd quarter. Bessemer Group Inc. now owns 727 shares of the company’s stock valued at $39,000 after buying an additional 567 shares in the last quarter. Liberty Wealth Management LLC lifted its position in shares of Nutrien by 340.5% during the 2nd quarter. Liberty Wealth Management LLC now owns 740 shares of the company’s stock valued at $40,000 after buying an additional 572 shares in the last quarter. FTB Advisors Inc. lifted its position in shares of Nutrien by 29.9% during the 1st quarter. FTB Advisors Inc. now owns 882 shares of the company’s stock valued at $46,000 after buying an additional 203 shares in the last quarter. Finally, Asset Dedication LLC lifted its position in shares of Nutrien by 90.8% during the 2nd quarter. Asset Dedication LLC now owns 1,034 shares of the company’s stock valued at $55,000 after buying an additional 492 shares in the last quarter. Institutional investors own 68.37% of the company’s stock.
Shares of NTR traded down $0.21 during midday trading on Tuesday, reaching $50.17. The company had a trading volume of 176,494 shares, compared to its average volume of 1,614,101. Nutrien Ltd has a 1-year low of $43.96 and a 1-year high of $58.99. The company has a market capitalization of $30.14 billion, a PE ratio of 18.64, a PEG ratio of 2.32 and a beta of 0.87. The business has a 50 day simple moving average of $52.21.
Nutrien (NYSE:NTR) last issued its quarterly earnings data on Monday, July 29th. The company reported $1.58 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.59 by ($0.01). The company had revenue of $8.66 billion during the quarter, compared to analysts’ expectations of $8.17 billion. The company’s revenue was up 6.8% on a year-over-year basis. During the same period last year, the firm earned $1.48 earnings per share. As a group, equities research analysts expect that Nutrien Ltd will post 2.83 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 17th. Investors of record on Monday, September 30th will be given a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 3.59%. This is an increase from Nutrien’s previous quarterly dividend of $0.43. The ex-dividend date of this dividend is Friday, September 27th. Nutrien’s dividend payout ratio (DPR) is presently 63.94%.
A number of research analysts have recently issued reports on NTR shares. TD Securities increased their target price on Nutrien from $68.00 to $69.00 and gave the company a “buy” rating in a research report on Wednesday, July 31st. Raymond James restated a “strong-buy” rating and issued a $70.00 price objective on shares of Nutrien in a report on Tuesday, July 30th. BMO Capital Markets set a $60.00 price objective on Nutrien and gave the company a “buy” rating in a report on Wednesday, July 31st. Citigroup set a $61.00 price objective on Nutrien and gave the company a “buy” rating in a report on Wednesday, July 31st. Finally, Cowen restated an “outperform” rating and issued a $63.00 price objective (down previously from $66.00) on shares of Nutrien in a report on Tuesday, April 23rd. Five research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company. Nutrien currently has a consensus rating of “Buy” and an average target price of $62.00.
Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations.
Further Reading: What is a conference call?
Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd (NYSE:NTR).
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.